c19early.org COVID-19 treatment researchCOVID-19 treatments

A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™ (Liposomal Bovine Lactoferrin (LbLf) and Liposomal Zn (LZn)) and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19

Avella et al., NCT05783180, NCT05783180, Nov 2024
Estimated 40 patient lactoferrin early treatment RCT with results not reported over 2 years after estimated completion.
Important missing comments or errors? Let us know.
Study covers lactoferrin and zinc.
Avella et al., 1 Nov 2024, Double Blind Randomized Controlled Trial, placebo-controlled, USA, trial NCT05783180 (history). Contact: maria.bertoli@keraltyhospital.com, gmasferrer@keraltyhospital.com.